At the Fortune Brainstorm Tech Dinner in Las Vegas, Fortune's Andrew Nusca interviews Mark Cuban about his work with Cost Plus Drugs. Cuban discusses disrupting the pharmaceutical industry, tackling ...

"There's nobody who looks at the healthcare system or the pharmaceutical industry and says ‘wow, that’s well run.'" ...

As criticism of pharmacy benefit managers heats up, fear of lawsuits is driving some big employers to drop the “Big Three” ...

Plus Oceans Healthcare adds five states with acquisition and UTA professor leads $1.8 million study.

thanks to a new alliance between PharmPix and Mark Cuban Cost Plus Drug Company (Cost Plus Drugs). With over 90% of prescribed drugs in the U.S. being generics, PharmPix and Cost Plus Drugs are ...

Mark Cuban is making his Cost Plus Drug Co. online pharmacy and discount card program a test of the proposition that the U.S. prescription drug market is just another market. Pramod John ...

Penn Medicine is partnering with billionaire investor Mark Cuban to streamline the availability of generic prescription drugs for its network of pharmacy locations. The nonprofit health system’s new ...

Medicare beneficiaries who take a lot of pricey medications will get a big break come 2025. That’s when the $2,000 annual cap ...

International price referencing for certain drugs could be revisited during the second Trump administration. But it's ...

Bipartisan bills in Congress would rein them in. And businesses such as Mark Cuban's Cost Plus Drugs and smaller, "transparent PBMs" have tried to wean pharmaceutical companies and health plans ...

UNITED STATES, — The start of 2025 marks the start of the capping of prescription drug costs for Medicare Part D recipients.